RIPK4 and ovarian cancer: These findings are in agreement with the observation that increased RIPK4 expression or high RIPK4 copy number correlated with progression and poor prognosis in patients suffering from cervical squamous cell carcinoma, colorectal cancer, ovarian cancer or bladder urothelial carcinoma [164–166].